Skip to main content
. 2018 Jan 6;9(15):12186–12200. doi: 10.18632/oncotarget.24069

Table 2. Demographic and clinical characteristics of included participants.

Variables Health Group Disease Group Comparison Group
Subgroup P Subgroup P Subgroup P
H1 H2 P1 P2 H3 P3
Patients (n) 20 20 20 19 20 20
Mean age (year) 31.0 ± 7.5 29.9 ± 7.4 0.64 30.9 ± 8.8 31.5 ± 8.3 0.82 28.1 ± 7.0 30.8 ± 8.0 0.25
Body mass index (kg/m2) 22.2 ± 1.7 21.8 ± 1.7 0.38 22.3 ± 1.6 21.7 ± 1.7 0.23 22.3 ± 1.7 21.7 ± 1.7 0.34
Marital status (n)
 Living with a partner 13 (65%) 12 (60%) 0.74 11 (55%) 13 (68%) 0.39 12 (60%) 13 (65%) 0.74
 Single 7 (35%) 8 (40%) 9 (45%) 6 (32%) 8 (40%) 7 (35%)
Employment status (n)
 Employed 15 (75%) 14 (70%) 0.72 19 (95%) 13 (68%) 0.03 19 (95%) 14 (70%) 0.04
 Unemployed 5 (25%) 6 (30%) 1 (5%) 6 (32%) 1 (5%) 6 (30%)
Sexual activity a
 ≤ 2 times weekly 12 (60%) 10 (50%) 0.53 13 (65%) 11 (58%) 0.65 13 (65%) 12 (60%) 0.11
 ≥3 times weekly 8 (40%) 10 (50%) 7 (35%) 8 (42%) 7 (35%) 8 (40%)
Duration of pain (months) 0 0 1.00 6.3 ± 2.0 6.4 ± 2.2 0.86 0 5.9 ± 2.2 0.00
Total NIH-CPSI score 3.8 ± 2.5 4.3 ± 2.3 0.51 30.0 ± 4.2 26.9 ± 4.8 0.04 4.9 ± 1.8 30.7 ± 5.0 0.00
 Total pain score 1.7 ± 1.5 2.0 ± 1.4 0.52 16.8 ± 2.6 15.3 ± 2.8 0.10 2.7 ± 1.5 16.7 ± 2.6 0.00
 Total urination score 1.0 ± 0.9 1.2 ± 0.9 0.49 6.1 ± 2.3 4.4 ± 1.6 0.01 0.8 ± 0.6 5.8 ± 2.6 0.00
 Quality of life score 1.2 ± 1.1 1.2 ± 1.1 1.00 7.1 ± 2.8 7.2 ± 2.7 0.86 1.4 ± 1.1 8.2 ± 2.9 0.00
Pain area
 Perineum 3 (15%) 2 (10%) 0.63 16 (80%) 16 (84%) 0.73 6 (30%) 17 (85%) 0.00
 Testicles 2 (10%) 2 (10%) 1.00 15 (75%) 10 (53%) 0.15 4 (20%) 13 (65%) 0.00
 Penis 5 (25%) 0 (0%) 0.02 14 (70%) 8 (42%) 0.08 5 (25%) 13 (65%) 0.01
 Pubic 2 (10%) 1 (5%) 0.55 13 (65%) 8 (42%) 0.15 3 (15%) 11 (55%) 0.01
Pain during urination 2 (10%) 4 (20%) 0.38 17 (85%) 11 (58%) 0.06 2 (10%) 15 (75%) 0.00
Pain during ejaculation 0 (0%) 5 (25%) 0.02 17 (85%) 13 (68%) 0.22 2 (10%) 14 (70%) 0.00
IIEF-5 score b 20.9 ± 4.6 20.5 ± 3.1 0.72 18.5 ± 4.3 16.7 ± 5.0 0.25 22.3 ± 2.3 15.7 ± 5.6 0.00
Perceived Stress Scale 14.6 ± 8.3 12.9 ± 8.4 0.51 20.0 ± 11.1 22.2 ± 10.5 0.54 12.5 ± 7.5 20.4 ± 9.8 0.00
Abstinent days c 7.2 ± 2.5 6.5 ± 2.5 0.38 6.0 ± 2.4 6.6 ± 2.6 0.44 6.1 ± 2.0 6.2 ± 2.3 0.94
Mean EPS volume (ul)
 ≤ 500 8 (40%) 8 (40%) 1.00 8 (40%) 11 (58%) 0.26 11 (55%) 10 (50%) 0.75
 ≥ 500 12 (60%) 12 (60%) 12 (60%) 8 (42%) 9 (45%) 10 (50%)
WBC/HP in EPS d
 I grade 20 (100%) 20 (100%) 1.00 0 0 0.07 20 (100%) 0 0
 II grade 0 0 9 (45%) 14 (74%) 0 13 (65%)
 III grade 0 0 11 (55%) 5 (26%) 0 7 (35%)

a : Sexual activity in previous 6 months. b : The score of International Index of Erectile Function 5. c : Abstinent days before EPS collection. d : WBC count in EPS was classified into three grades: I grade: < 10/high power field (HP), II grade: 10∼20/HP, III grade: >20/HP.